BUY Aster DM Healthcare Limited — Vikas Sethi, Sethi Finmart
byVikas Sethi, Sethi FinmartHorizon: 1–3 months17 Aug 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Broker’s Call: Aster DM Healthcare (Buy)
NewsHbl·8 Aug · 2w ago
Aster DM Quality Care Limited has acquired equity shares of United CIIGMA Institute of Medical Sciences, a subsidiary.
NSE · Acquisition·5 Aug · 2w ago
Aster DM Quality Care Limited announced strong Q1 FY27 financial results with revenue up 20% to INR 2,597 Cr and operating EBITDA up 30% to INR 576 Cr. The company also highlighted the merger becoming
NSE · Press Release·5 Aug · 2w ago
CRISIL has assigned credit ratings to Aster DM Quality Care Ltd's bank facilities: AA+/Stable for long-term (860.50 crore) and A1+ for short-term (assigned). These ratings were novated following the c
BSE · Company Update·30 Jul · 3w ago
Dr. Azad Moopen Meets Shri D.K. Shivakumar; Reaffirms Aster DM Quality Cares Commitment to Karnataka with Rs 1,315 Crore Investment
NewsGoogle News·25 Jul · 3w ago
Aster DM Quality Care Block Deal: Shares worth nearly ₹7,800 crore change hands
NewsCnbc-Tv18·19 Aug · today
Aster DM Healthcare: 35.35 Billion Shares Approved for Trading Post-Amalgamation
NewsGoogle News·14 Aug · 4d ago
Broker’s Call: Aster DM Healthcare (Buy)
NewsHbl·7 Aug · 2w ago
Aster DM Quality Care Limited announced its unaudited financial results for the quarter ended June 30, 2026. The results were reviewed by the Audit Committee and approved by the Board of Directors.
NSE · Outcome of Board Meeting·5 Aug · 2w ago
Aster DM Healthcare to rename as Aster DM Quality Care Limited
NewsGoogle News·25 Jul · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.